No abstract available.
Humans* ; Prostate* ; Prostatic Neoplasms*

No abstract available.
Humans* ; Prostate* ; Prostatic Neoplasms*

PURPOSE: The purpose of this study to analyze the relationship the activities of daily living(ADL), self-efficacy, and health promoting behaviors. METHOD: The research was a descriptive survey study. The subjects of this study were 115 hospitalized stroke patients to two General hospitals and one Oriental treatment hospital in G. Metropolitan. Data was collected through questionnaires from December 1st, 2003 to January 30th, 2004. The survey instruments used in the study Shah, Vanclay and Cooper's MBI(11 items), and Sherer and Maddux's self-efficacy(10 items), Walker, Sechrist, and Pender's HPLP(23 items) was developed by the researcher. The obtain data were analyzed with an SPSS 10.0 program using frequency, percentage, Cronbach's alpha, t-test, ANOVA, Duncan test, and Pearson's correlation coefficient. RESULT: The results were as follows; The level of ADL the score was 50.5, self-efficacy 40.4, and health promoting behavior 54.6. There were significant differences of ADL by general and disease related characteristics as follows : for monthly income(F=2.72, p= .048), duration of stroke(F=7.98, p= .001), number of attack(F=5.21, p= .007), operation (F=17.88, p= .000). There were significant differences of self-efficacy by general and disease related characteristics as follows : for monthly income(F=4.83, p= .003), number of attack (F= 6.20, p=. 003), operation(F=4.03, p= .047). There were significant differences of health promoti ng behaviors by general and disease-related characteristics as follows : for aphasia(F=4.24, p=.042). There were significant correlated between ADL and self-efficacy(r= .698, p=.000), self- efficacy and health promoting behavior(r=.398, p= .000), ADL and health promoting behavior(r= .235, p= .011). CONCLUSION: As a result, There was a significant correlation between ADL, self-efficacy and health promoting behaviors. There will be considered useful nursing intervention effect to progress, support health promoting behavior of stroke patients.
Activities of Daily Living* ; Hospitals, General ; Humans ; Nursing ; Surveys and Questionnaires ; Stroke*

No abstract available.

No abstract available.
Depression*

Essential hypertension is an important public health problem in Korea-being common, asymptomatic, easily treatable, and often leading to lethal complication in left untreated. The number of patients with hypertension has been significantly increased, and this factor may be an importnat one responsible for the increase in cardivascular mortality during past 20 years in Korea. As the drug therapy for hypertension needs longer period, it is very important to evaluate the efficacy and the adverse effects. Thirty patients(17 men and 13 womon) with essential hypertension were evaluated in this study. All patients had received oral Isradipine 1.25~2.5mg b.i.d. for 8 weeks. 1) The systolic and diastolic pressure were decreased significantly(166.8+/-9.0mmHg vs 147.3+/-12.0mmHg, p<0.001 and 100.3+/-4.0mmHg vs 90.3+/-6.1mmHg, p<0.001, respectively) 2) Heart rate, body weight, laboratory tests, chest X-ray, ECG studies were not changed significantly. 3) The systolic pressure was lowered by 20mmHg or more in 17 cases(56.7% of total), and the diastolic pressure was lowered by 10mmHg or more in 20 cases(66.7% of total) at 8 weeks after Isradipine administration. 4) The adverse effects of Isradipine were edema in 3(10%), constipation in 2(6.7%), headache in 2(6.7%), and insomnia, dizziness and dry mouth in 1 patient respectively, and none of them discontinued Isradipine administration due to adverse effects. In many patients with essential hypertension there is an effective response to Isradipine, even though there may be some mild adverse effects.
Blood Pressure ; Body Weight ; Constipation ; Dizziness ; Drug Therapy ; Edema ; Electrocardiography ; Headache ; Heart Rate ; Humans ; Hypertension ; Isradipine ; Korea ; Male ; Mortality ; Mouth ; Public Health ; Sleep Initiation and Maintenance Disorders ; Thorax

Faced with patients who underwent TURP and who were given antibiotics until catheter-removal, usually complain of urinary frequency or burning on ruination and showing sterile urine (less than l00 bacteria per ml., in clean-caught midstream about 24 hours after catheter-removal), we often hesitate to make a decision whether they should be given antibiotics or not. So we divided 27 such patients into three groups : group l ; 7 patients, no additional antibiotics after catheter-removal, group 2; 12 patients, antibiotics for one week after catheter-removal and we performed weekly urine culture for clarifying the necessity of additional antibiotic therapy and its appropriate duration, if necessary. The following results and conclusions were obtained. I. Group l showed bacteriuria in 86%(6 of 7 patients). 2.Group 2 and 3 showed bacteriuria 5%(1 of 20 patients). 3. These data suggested that additional antibiotic therapy rather than stopping antibiotic therapy might be justified(P : less than 0.001). 4. Group 2 showed no bacteriuria and group 3 showed bacteriuria in one patient which disappeared promptly. Namely, there was no practical difference in the incidence of bacteriuria between the two groups. 5. 9 cases of fungiuria were found, all of which developed in patients given antibiotics perioperatively for more than 2 weeks. 6. Considering the above items and cost-effectiveness, a week`s additional antibiotic therapy is probably an appropriate answer to treating the above-mentioned patients. 7. Main causative organism in post-TURP bacteriuria was Pseudomonas spp(4of 7 cases).
Anti-Bacterial Agents* ; Bacteria ; Bacteriuria ; Burns ; Humans ; Incidence ; Pseudomonas ; Transurethral Resection of Prostate* ; Urinary Catheters

No abstract available.
Epidemiologic Studies* ; Methicillin Resistance* ; Methicillin-Resistant Staphylococcus aureus* ; Plasmids*

No abstract available.
Epidemiologic Studies* ; Methicillin Resistance* ; Methicillin-Resistant Staphylococcus aureus* ; Plasmids*

No abstract available.
DNA Restriction Enzymes* ; DNA* ; Ribotyping* ; Staphylococcus aureus* ; Staphylococcus*